Sanofi Current Ratio 2006-2019 | SNY

Current and historical current ratio for Sanofi (SNY) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Sanofi current ratio for the three months ending June 30, 2019 was .
Sanofi Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $28.45B $21.59B 1.32
2019-03-31 $0.00B 0.00
2018-03-31 $0.00B 0.00
2017-12-31 $29.79B $17.47B 1.71
2017-09-30 $0.00B 0.00
2017-06-30 $29.78B $18.76B 1.59
2017-03-31 $0.00B 0.00
2016-12-31 $29.53B $18.19B 1.62
2016-09-30 $0.00B 0.00
2016-06-30 $25.23B $17.22B 1.47
2016-03-31 $0.00B 0.00
2015-09-30 $0.00B 0.00
2015-06-30 $24.35B $18.03B 1.35
2014-06-30 $27.94B $19.48B 1.43
2013-06-30 $27.17B $17.80B 1.53
2012-06-30 $27.56B $20.66B 1.33
2012-03-31 $0.00B 0.00
2011-12-31 $29.05B $18.92B 1.54
2011-09-30 $0.00B 0.00
2011-06-30 $32.57B $23.10B 1.41
2011-03-31 $0.00B 0.00
2010-12-31 $35.96B $15.62B 2.30
2010-09-30 $0.00B 0.00
2010-06-30 $31.89B $15.40B 2.07
2010-03-31 $0.00B 0.00
2009-12-31 $33.30B $17.29B 1.93
2009-09-30 $0.00B 0.00
2009-06-30 $25.23B $14.69B 1.72
2009-03-31 $0.00B 0.00
2008-12-31 $22.66B $13.75B 1.65
2008-09-30 $0.00B 0.00
2008-06-30 $18.62B $14.01B 1.33
2008-03-31 $0.00B 0.00
2007-12-31 $17.21B $13.25B 1.30
2007-09-30 $0.00B 0.00
2007-06-30 $16.75B $13.18B 1.27
2007-03-31 $0.00B 0.00
2006-12-31 $15.28B $12.91B 1.18
2006-09-30 $0.00B 0.00
2006-06-30 $15.45B $17.89B 0.86
2006-03-31 $0.00B 0.00
2005-12-31 $16.34B $19.20B 0.85
2005-09-30 $0.00B 0.00
2005-06-30 $16.55B $20.53B 0.81
2005-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $109.681B $40.701B
Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $344.226B 14.99
Roche Holding AG (RHHBY) Switzerland $232.232B 0.00
Merck (MRK) United States $213.305B 17.54
Pfizer (PFE) United States $206.197B 12.14
Novartis AG (NVS) Switzerland $205.316B 17.65
Novo Nordisk (NVO) Denmark $117.619B 20.78
AstraZeneca (AZN) United Kingdom $112.559B 21.78
Eli Lilly (LLY) United States $107.617B 20.08
AbbVie (ABBV) United States $104.721B 8.39
GlaxoSmithKline (GSK) United Kingdom $102.338B 12.86
Bristol-Myers Squibb (BMY) United States $81.150B 11.51
Bayer (BAYRY) Germany $70.202B 10.23
H Lundbeck (HLUYY) Denmark $7.119B 10.27